Brief: Nicox Licensee Bausch + Lomb Launches Vyzulta In Taiwan, Approved In Qatar

Nicox SA

04/05/2021 07:02

May 4 (Reuters) - Nicox SA  NCOX.PA :
    * REG-NICOX’S LICENSEE BAUSCH + LOMB LAUNCHES  VYZULTA®
(LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION), 0.024% IN TAIWAN AND
RECEIVES APPROVAL IN QATAR
    * UNDER TERMS OF EXCLUSIVE GLOBAL LICENSE AGREEMENT, NICOX
RECEIVES INCREASING TIERED ROYALTIES OF 6% TO 12% ON NET GLOBAL
SALES OF VYZULTA
    * UNDER TERMS OF AGREEMENT, NICOX RECEIVES UP TO $150
MILLION IN
POTENTIAL FUTURE MILESTONE PAYMENTS

Source text for Eikon:  ID:nGNE3vhKdv 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))